O’Hearn et al. reported that vitreous vascular endothelial growth factor (VEGF) levels in FAP patients were raised to similar levels as those found in patients with inactive proliferative diabetic retinopathy[13]. This evidence concerns the gene VEGFA and proliferative diabetic retinopathy.